Fig. 2.
![Changes from baseline (95% CIs) over time for (A) activated partial thromboplastin time (aPTT) and (B) prothrombin time (international normalized ratio) (PT[INR]) (all-patients-as-treated population), using a constrained longitudinal data analysis method. For sugammadex, N = 567, and for usual care, N = 545.](https://asa2.silverchair-cdn.com/asa2/content_public/journal/anesthesiology/121/5/10.1097_aln.0000000000000424/3/17ff02.png?Expires=1716904325&Signature=byuV-qFKZRjtTLciBj5yu6j1CsPwNhMaV1Xmujih-V5WZba8OGqf5MnjsT0XVxllJ2q4DOvmK~W39clx6rJR8-72nLTBMT8Nc-mn4sIVscjitCINVqTyP1tHu4n6ukkwvaHIlv0ig7yKuiU9PbHLFUL1O0gwXYfxmbOdaLKGkQpuRevlwsbqkw9kcnqsQPSKMkbHW8tZfqqXEp9ftzJfiVWwnvayM4iqEsK5fTTZAUqJVOuN~HyArDl29zBECjQVADa2RoSYEiqUZ~vrN7EGovHkbPEcqzRJpVQEQOPnK786uMR9qkg16ae7Hnw~txilPRQNR8mlxRJiVeYMTQhf1g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Changes from baseline (95% CIs) over time for (A) activated partial thromboplastin time (aPTT) and (B) prothrombin time (international normalized ratio) (PT[INR]) (all-patients-as-treated population), using a constrained longitudinal data analysis method. For sugammadex, N = 567, and for usual care, N = 545.
